Sep 29, 2022

Featuring a slide presentation and related discussion from Dr Amrita Krishnan, including the following topics:

• Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
• Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
• Belantamab...

Sep 29, 2022

Featuring an interview with Dr Amrita Krishnan, including the following topics:

• Case: A woman in her early 60s who presents with renal failure and receives CyBorD for multiple myeloma (MM) (0:00)
• Dyspnea associated with carfilzomib; ocular toxicity with belantamab mafodotin (6:26)
• Efficacy, tolerability and sequencing...

Sep 26, 2022

Featuring a slide presentation and related discussion from Dr Heather Wakelee, including the following topics:

• Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
• Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
• Belantamab...

Sep 26, 2022

Featuring an interview with Dr Heather Wakelee, including the following topics:

• Similarities and differences in the efficacy of neoadjuvant and adjuvant immunotherapies for localized non-small cell lung cancer (NSCLC) (0:00)
• Available data on the treatment of patients whose disease relapses on or after adjuvant...

Sep 23, 2022

Featuring perspectives from Dr Richard Penson, including the following topics:

• Introduction: Journal Club with Richard T Penson, MD, MRCP (0:00)
• Case: A woman in her mid 70s with Stage IIIB BRCA wild-type, high-grade serous ovarian cancer (HGSOC) who receives neoadjuvant and adjuvant carboplatin/paclitaxel and develops...